期刊文献+

趋化因子受体CXCR7在急性白血病中的表达及临床意义研究

Expression and Significance of Chemokine Receptor CXCR7 in Acute Leukemia
下载PDF
导出
摘要 目的探讨趋化因子受体CXCR7在急性白血病中的表达及意义。方法应用流式细胞术检测急性白血病组、对照组骨髓细胞表面CXCR7的表达。结果实验组骨髓细胞表面CXCR7的相对荧光强度(56.40±16.29)高于对照组(20.54±9.35),差异有统计学意义(P<0.05);急性淋巴细胞白血病组CXCR7的相对荧光强度(69.22±12.49)高于急性非淋巴细胞白血病组(47.16±11.90),差异有统计学意义(P<0.05);髓外浸润组CXCR7的表达(59.65±16.00)高于非髓外浸润组(48.01±14.45),差异有统计学意义(P<0.05);复发组、初诊组CXCR7的表达均高于部分缓解、完全缓解组,差异有统计学意义(P<0.05);实验组患者CXCR7的表达与骨髓幼稚细胞百分比呈正相关关系,相关系数为0.56(P<0.01)。结论趋化因子受体CXCR7在急性白血病中高表达,可能与白血病的发生、浸润等有关。 Objective To study the expression and significance of chemokine receptor CXCR7 in acute leukemia.Methods The expression of CXCR7 on bone marrow cell surface in the acute leukemia group and the control group was measured by flow cytometry.Results The relative fluorescence intensity of CXCR7 in the acute leukemia group was significantly higher than that in control group(P0.05).The relative fluorescence in intensity of CXCR7 in acute lymphoblastic leukemia group was significantly higher than that in acute non-lymphocytic leukemia group(P0.05).The expression of CXCR7 in extramedullary infiltration group was significantly higher than that in non-extramedulllary group(P0.05).The expression of CXCR7 in patients with recurrent diseases and newly diagnosed patients were significantly higher than that in patients experienced partial remission and complete remission(P0.05).The expression of CXCR7 in acute leukemia group was positive correlated with the percentage of marrow blasts,and the correlation coefficient was 0.56(P0.01).Conclusion Chemokine receptor CXCR7 is highly expressed in acute leukemia,which may be related to acute leukemia and infiltration.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第17期1951-1953,共3页 Chinese General Practice
基金 石河子大学医学院第一附属医院院级课题项目(YL2010-S013)
关键词 急性白血病 CXCR7 流式细胞术 Acute Leukemia CXCR7 Flow cytometry
  • 相关文献

参考文献9

  • 1Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4/CXCR7 chemo- kine axis and cancer progression [J]. Cancer Metastasis Rev, 2010, 29 (4): 709-722.
  • 2Faaij CM, Willemze AJ, R6v6sz T, et al. Chemokine/ChemokineRe- ceptorInteractions in Extramedullary Leukaemia of the Skin in Childhood AML: Differential Roles for CCR2, CCRS, CXCR4 and CXCR7 [J]. Pediatr Blood Cancer, 2010, 55 (2) : 344 -348.
  • 3Kittang AO, Hatfield K, Sand K, el al. The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leu- kemogenesis and Therapeutic Implications [ J]. Curr Top Microbiol Im- munol, 2010, 341 : 149 -172.
  • 4Kalinkovich A, Tavor S, Avigdor A, et al. F, unctional CXCR4 ex- pressing mieroparticles and SDF - 1 correlate with circulating acute my- elogenous leukemia cells [J]. Cancer Res, 2006, 66 (22) : 11013 - 11020.
  • 5MiaoZ, Luker KE, Summers BC, et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor associated vasculature [J]. ProcNatl Acad Sci USA, 2007, 104 (40): 15735 - 15740.
  • 6Maciej T, Rui L, Marcin W, et al. CXCR7 : a new SDF - 1 - bind- ing receptor in contrast to normal CD34 ( + ) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells [J]. EurJHaematol, 2010, 85 (6): 472-483.
  • 7Ali J, Neeta S, Imran M, et al. CXCR7 is Expressed in B Acute Lym- phoblastic Leukemia (ALL) Ceils and Mediates Their Transendothelial Migration [J]. ASH Annual Meeting Abstracts, 2008, 112 ( 11 ) : 1916.
  • 8Zhe J, Daisuke N, Aiko - Konno S, et al. CXCR7 is inducible by HTLV - 1 Tax and promotes growth and survival of HTLV - 1 - infected T cells [J]. Int J Cancer, 2009, 125 (9) : 2229 -2235.
  • 9Calatozzolo C, Canazza A, Polio B, et al. Expression of the new CX- CL 12 receptor, CXCR7, in gliomas [J]. Cancer Biol Ther, 2011, 11 (2) : 242 -253.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部